Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Review

Published on 11 Aug 2022

Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field

in Pharmacology of Anti-Cancer Drugs

Kunming Cheng
Qiang Guo
Zefeng Shen
Weiguang Yang
Yan Zhou
Zaijie Sun
Xiuhua Yao
Haiyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.948389

11,582 views
27 citations

Original Research

Published on 10 Aug 2022

Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C

in Pharmacology of Anti-Cancer Drugs

Haiming Zhuang
Jigang Fan
Mingyu Li
Hao Zhang
Xiuyan Yang
Ligen Lin
Shaoyong Lu
Qing Wang
Yaqin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.915512

3,810 views
14 citations

Review

Published on 08 Aug 2022

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer

in Pharmacology of Anti-Cancer Drugs

Liyun Yong
Shasha Tang
Haixin Yu
Hongyi Zhang
Yi Zhang
Yuan Wan
Fengfeng Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.964934

8,889 views
49 citations

Review

Published on 08 Aug 2022

Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application

in Pharmacology of Anti-Cancer Drugs

Takashi Higuchi
Kentaro Igarashi
Norio Yamamoto
Katsuhiro Hayashi
Hiroaki Kimura
Shinji Miwa
Michael Bouvet
Hiroyuki Tsuchiya
Robert M. Hoffman

Frontiers in Oncology

doi 10.3389/fonc.2022.957844

4,055 views
14 citations

Original Research

Published on 05 Aug 2022

Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy

in Pharmacology of Anti-Cancer Drugs

Marcin Opławski
Agata Średnicka
Ewa Niewiadomska
Dariusz Boroń
Piotr Januszyk
Beniamin Oskar Grabarek

Frontiers in Oncology

doi 10.3389/fonc.2022.954008

3,184 views
15 citations

Editorial

Published on 05 Aug 2022

Editorial: Multi-target directed ligands for the treatment of cancer

in Pharmacology of Anti-Cancer Drugs

Margherita Brindisi
Sonja M. Kessler
Vinod Kumar
Clemens Zwergel

Frontiers in Oncology

doi 10.3389/fonc.2022.980141

2,433 views
16 citations

Original Research

Published on 04 Aug 2022

Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study

in Pharmacology of Anti-Cancer Drugs

Silpa Narayanan
Qiu-Xu Teng
Zhuo-Xun Wu
Urooj Nazim
Nishant Karadkhelkar
Nikita Acharekar
Sabesan Yoganathan
Najia Mansoor
Feng-Feng Ping
Zhe-Sheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.949868

3,303 views
5 citations

Correction

Published on 04 Aug 2022

Corrigendum: The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: A SEER population-based analysis

in Pharmacology of Anti-Cancer Drugs

Qi Lin
Jia-Hao Bao
Fei Xue
Jia-Jun Qin
Zhen Chen
Zhong-Rong Chen
Chao Li
Yi-Xuan Yan
Jin Fu
Zhao-Li Shen

Frontiers in Oncology

doi 10.3389/fonc.2022.995352

1,456 views

Original Research

Published on 04 Aug 2022

Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

in Pharmacology of Anti-Cancer Drugs

Qian Zhao
Shan-Shan Xiong
Can Chen
Hong-Ping Zhu
Xin Xie
Cheng Peng
Gu He
Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2022.972372

11,035 views
11 citations

Case Report

Published on 03 Aug 2022

Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review

in Pharmacology of Anti-Cancer Drugs

Peiyi Xie
Lei Guo
Bo Zhang
Yongfeng Xu
Qi Song
Hongcheng Shi
Qinghai Ye
Hui Li
Yongsheng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.911202

4,381 views
6 citations

Brief Research Report

Published on 02 Aug 2022

Long-Read Sequencing Annotation of the Transcriptome in DNA-PK Inactivated Cells

in Pharmacology of Anti-Cancer Drugs

Liwei Song
Mengjun Yu
Renjing Jin
Meng Gu
Ziyu Wang
Dailun Hou
Shaofa Xu
Jinghui Wang
Teng Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.941638

3,329 views
1 citation

Original Research

Published on 01 Aug 2022

LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1

in Pharmacology of Anti-Cancer Drugs

Min Ling
Qing Liu
Yufei Wang
Xueting Liu
Manli Jiang
Jinyue Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.937444

4,255 views
14 citations

Editorial

Published on 29 Jul 2022

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics

in Pharmacology of Anti-Cancer Drugs

Tashinga E. Bapiro
Rose Hayeshi
Collet Dandara

Frontiers in Oncology

doi 10.3389/fonc.2022.972718

1,369 views

Review

Published on 29 Jul 2022

Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action

in Pharmacology of Anti-Cancer Drugs

Caitlin M. Tilsed
Scott A. Fisher
Anna K. Nowak
Richard A. Lake
W. Joost Lesterhuis

Frontiers in Oncology

doi 10.3389/fonc.2022.960317

29,469 views
109 citations

Original Research

Published on 28 Jul 2022

The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset

in Pharmacology of Anti-Cancer Drugs

Weidong Liu
Yuedong Hao
Xiao Tian
Jing Jiang
Quanhe Qiu

Frontiers in Oncology

doi 10.3389/fonc.2022.879288

4,016 views
4 citations

Original Research

Published on 28 Jul 2022

Cell Death Triggers Induce MLKL Cleavage in Multiple Myeloma Cells, Which may Promote Cell Death

in Pharmacology of Anti-Cancer Drugs

Jing Chen
Shiyu Wang
Bart Blokhuis
Rob Ruijtenbeek
Johan Garssen
Frank Redegeld

Frontiers in Oncology

doi 10.3389/fonc.2022.907036

4,136 views
5 citations